Capricor Therapeutics, Inc. announced that on January 20, 2014, the employment of Anthony Davies as the company's Chief Technology Officer was terminated by mutual agreement of the company and Mr. Davies, effective immediately.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 USD | -2.27% |
|
-1.34% | +5.73% |
Jun. 11 | Sector Update: Health Care Stocks Decline Tuesday Afternoon | MT |
Jun. 11 | Capricor Says FDA Grants Pre-BLA Meeting Request for Duchenne Muscular Dystrophy Treatment; Shares Rise | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.73% | 165M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- CAPR Stock
- News Capricor Therapeutics, Inc.
- Capricor Therapeutics, Inc. Announces Termination of Employment of Anthony Davies as Chief Technology Officer